Fidelity Investments’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.65M Sell
169,362
-4,889
-3% -$105K ﹤0.01% 2272
2025
Q1
$2.89M Buy
174,251
+36,226
+26% +$602K ﹤0.01% 2333
2024
Q4
$2.53M Buy
138,025
+40,667
+42% +$746K ﹤0.01% 2369
2024
Q3
$1.5M Sell
97,358
-2,269,618
-96% -$34.9M ﹤0.01% 2478
2024
Q2
$38.5M Sell
2,366,976
-1,626,830
-41% -$26.4M ﹤0.01% 1415
2024
Q1
$73.8M Sell
3,993,806
-1,271,552
-24% -$23.5M 0.01% 1173
2023
Q4
$165M Sell
5,265,358
-36,622
-0.7% -$1.15M 0.01% 825
2023
Q3
$110M Sell
5,301,980
-19,257
-0.4% -$401K 0.01% 927
2023
Q2
$127M Sell
5,321,237
-2,525,436
-32% -$60.5M 0.01% 897
2023
Q1
$148M Sell
7,846,673
-1,487,941
-16% -$28M 0.01% 835
2022
Q4
$149M Sell
9,334,614
-2,236,411
-19% -$35.6M 0.01% 810
2022
Q3
$189M Sell
11,571,025
-827,932
-7% -$13.5M 0.02% 688
2022
Q2
$175M Sell
12,398,957
-1,082,492
-8% -$15.3M 0.02% 749
2022
Q1
$327M Sell
13,481,449
-359,301
-3% -$8.7M 0.03% 591
2021
Q4
$323M Sell
13,840,750
-2,035,794
-13% -$47.5M 0.02% 612
2021
Q3
$264M Buy
15,876,544
+377,406
+2% +$6.27M 0.02% 687
2021
Q2
$378M Sell
15,499,138
-1,688,345
-10% -$41.2M 0.03% 550
2021
Q1
$443M Sell
17,187,483
-2,285,431
-12% -$59M 0.04% 469
2020
Q4
$1.04B Sell
19,472,914
-275,434
-1% -$14.7M 0.09% 198
2020
Q3
$815M Sell
19,748,348
-1,041,956
-5% -$43M 0.08% 217
2020
Q2
$1.01B Buy
20,790,304
+499,407
+2% +$24.2M 0.11% 168
2020
Q1
$857M Sell
20,290,897
-600,020
-3% -$25.4M 0.12% 155
2019
Q4
$894M Sell
20,890,917
-1,855,327
-8% -$79.4M 0.1% 195
2019
Q3
$819M Buy
22,746,244
+1,121,356
+5% +$40.4M 0.1% 205
2019
Q2
$578M Buy
21,624,888
+42,531
+0.2% +$1.14M 0.07% 284
2019
Q1
$579M Buy
21,582,357
+38,464
+0.2% +$1.03M 0.07% 275
2018
Q4
$348M Buy
21,543,893
+2,792,885
+15% +$45.2M 0.05% 387
2018
Q3
$389M Buy
18,751,008
+27,113
+0.1% +$563K 0.04% 416
2018
Q2
$286M Buy
18,723,895
+18,604
+0.1% +$284K 0.03% 514
2018
Q1
$420M Buy
18,705,291
+74,446
+0.4% +$1.67M 0.05% 394
2017
Q4
$561M Buy
18,630,845
+270,800
+1% +$8.15M 0.07% 316
2017
Q3
$692M Buy
18,360,045
+53,079
+0.3% +$2M 0.08% 255
2017
Q2
$511M Buy
18,306,966
+95,823
+0.5% +$2.67M 0.06% 311
2017
Q1
$626M Buy
18,211,143
+44,067
+0.2% +$1.52M 0.08% 265
2016
Q4
$524M Buy
18,167,076
+68,724
+0.4% +$1.98M 0.07% 303
2016
Q3
$576M Buy
18,098,352
+1,128,901
+7% +$35.9M 0.08% 272
2016
Q2
$551M Buy
16,969,451
+78,983
+0.5% +$2.56M 0.08% 282
2016
Q1
$472M Buy
16,890,468
+1,753,725
+12% +$49M 0.07% 313
2015
Q4
$540M Buy
15,136,743
+29,516
+0.2% +$1.05M 0.07% 282
2015
Q3
$500M Buy
15,107,227
+62,614
+0.4% +$2.07M 0.07% 304
2015
Q2
$630M Buy
15,044,613
+18,856
+0.1% +$790K 0.08% 274
2015
Q1
$490M Buy
15,025,757
+60,212
+0.4% +$1.96M 0.06% 354
2014
Q4
$475M Buy
14,965,545
+50,022
+0.3% +$1.59M 0.06% 351
2014
Q3
$369M Buy
14,915,523
+72,075
+0.5% +$1.78M 0.05% 403
2014
Q2
$335M Buy
14,843,448
+218,055
+1% +$4.93M 0.04% 446
2014
Q1
$356M Buy
14,625,393
+995,423
+7% +$24.2M 0.05% 400
2013
Q4
$341M Buy
13,629,970
+301,805
+2% +$7.54M 0.05% 416
2013
Q3
$366M Buy
13,328,165
+73,430
+0.6% +$2.02M 0.06% 386
2013
Q2
$241M Buy
+13,254,735
New +$241M 0.04% 505